KELLIE ADESINA

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. Build Back Better proposals, including H.R. 5376, the Build Back Better Act. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. Build Back Better proposals, including H.R. 5376, the Build Back Better Act. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 5376, Inflation Reduction Act of 2022. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 5376, Inflation Reduction Act of 2022. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and administrative action related to social justice issues. H.R. 5, Equality Act.

Monitor legislative and administrative action related to social justice issues. H.R. 5, Equality Act.

Monitor legislative and administrative action related to social justice issues. H.R. 5, Equality Act.

Monitor legislative and administrative action related to social justice issues. H.R. 5, Equality Act.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to agricultural chemistry. Monitor legislative and administrative action related to biotechnology. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Monitor legislative and administrative action related to the programs of the Natural Resources Conservation Service (NRCS). Monitor legislative and administrative action related to White House Conference on Hunger. Monitor legislative and administrative action related to food security and nutrition. Monitor legislative and administrative action related to Russian and Ukraine food security. Build Back Better proposals, including H.R. 5376, the Build Back Better Act.

Monitor legislative and administrative action on appropriations and budget. Monitor the implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58). H.R. 5376, Inflation Reduction Act of 2022. H.R. 6833, Making continuing appropriations for fiscal year 2023, and for other purposes.

Monitor legislative and federal activity related to tax reform. Monitor legislative and administrative action related to corporate and international tax, including issues related to tax code sections 172, 245A, 951A, 59A, 163(j), and 965. Monitor legislative and administrative action related to implementation of P.L. 115-97, Tax Cuts and Jobs Act. Monitor legislative and administrative action related to including dietary supplements as reimbursable expenses in tax-preferred savings accounts. Monitor legislative and administrative issues related to foreign tax credit regulations. H.R. 5376, Inflation Reduction Act of 2022. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and administrative action on appropriations and budget. Monitor the implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58). H.R. 5376, Inflation Reduction Act of 2022. H.R. 6833, Making continuing appropriations for fiscal year 2023, and for other purposes.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. Build Back Better proposals, including H.R. 5376, the Build Back Better Act. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to agricultural chemistry. Monitor legislative and administrative action related to biotechnology. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Monitor legislative and administrative action related to the programs of the Natural Resources Conservation Service (NRCS). Monitor legislative and administrative action related to White House Conference on Hunger. Monitor legislative and administrative action related to food security and nutrition. Monitor legislative and administrative action related to Russian and Ukraine food security. Monitor legislative and administrative action related to the International Union for the Protection of New Varieties of Plants (UPOV). H.R. 5376, Inflation Reduction Act of 2022.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 5376, Inflation Reduction Act of 2022. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. Build Back Better proposals, including H.R. 5376, the Build Back Better Act. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and federal activity related to tax reform. Monitor legislative and administrative action related to corporate and international tax, including issues related to tax code sections 172, 245A, 951A, 59A, 163(j), and 965. Monitor legislative and administrative action related to implementation of P.L. 115-97, Tax Cuts and Jobs Act. Monitor legislative and administrative action related to including dietary supplements as reimbursable expenses in tax-preferred savings accounts. Monitor legislative and administrative issues related to foreign tax credit regulations. H.R. 5376, Inflation Reduction Act of 2022. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and federal activity related to tax reform. Monitor legislative and administrative action related to corporate and international tax, including issues related to tax code sections 172, 245A, 951A, 59A, 163(j), and 965. Monitor legislative and administrative action related to implementation of P.L. 115-97, Tax Cuts and Jobs Act. Monitor legislative and administrative action related to including dietary supplements as reimbursable expenses in tax-preferred savings accounts. Monitor legislative and administrative issues related to foreign tax credit regulations. Build Back Better proposals, including H.R. 5376, the Build Back Better Act. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to agricultural chemistry. Monitor legislative and administrative action related to biotechnology. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Monitor legislative and administrative action related to the programs of the Natural Resources Conservation Service (NRCS). Monitor legislative and administrative action related to White House Conference on Hunger. Monitor legislative and administrative action related to food security and nutrition. Monitor legislative and administrative action related to Russian and Ukraine food security. Build Back Better proposals, including H.R. 5376, the Build Back Better Act.

Monitor legislative and federal activity related to tax reform. Monitor legislative and administrative action related to corporate and international tax, including issues related to tax code sections 172, 245A, 951A, 59A, 163(j), and 965. Monitor legislative and administrative action related to implementation of P.L. 115-97, Tax Cuts and Jobs Act. Monitor legislative and administrative action related to including dietary supplements as reimbursable expenses in tax-preferred savings accounts. Monitor legislative and administrative issues related to foreign tax credit regulations. Build Back Better proposals, including H.R. 5376, the Build Back Better Act. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to agricultural chemistry. Monitor legislative and administrative action related to biotechnology. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Monitor legislative and administrative action related to the programs of the Natural Resources Conservation Service (NRCS). Monitor legislative and administrative action related to White House Conference on Hunger. Monitor legislative and administrative action related to food security and nutrition. Monitor legislative and administrative action related to Russian and Ukraine food security. Monitor legislative and administrative action related to the International Union for the Protection of New Varieties of Plants (UPOV). H.R. 5376, Inflation Reduction Act of 2022.

Monitor legislative and administrative action on appropriations and budget. Monitor the implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58). Build Back Better proposals, including H.R. 5376, the Build Back Better Act.

Monitor legislative and administrative action on appropriations and budget. Monitor the implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58). Build Back Better proposals, including H.R. 5376, the Build Back Better Act.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 5376, Inflation Reduction Act of 2022. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and administrative action on appropriations and budget. Monitor the implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58). H.R. 5376, Inflation Reduction Act of 2022. H.R. 6833, Making continuing appropriations for fiscal year 2023, and for other purposes.

Monitor legislative and administrative action on appropriations and budget. Monitor the implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58). H.R. 5376, Inflation Reduction Act of 2022. H.R. 6833, Making continuing appropriations for fiscal year 2023, and for other purposes.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 5376, Inflation Reduction Act of 2022. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. Build Back Better proposals, including H.R. 5376, the Build Back Better Act. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. Build Back Better proposals, including H.R. 5376, the Build Back Better Act. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 5376, Inflation Reduction Act of 2022. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 5376, Inflation Reduction Act of 2022. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 5376, Inflation Reduction Act of 2022. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. Build Back Better proposals, including H.R. 5376, the Build Back Better Act. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. Build Back Better proposals, including H.R. 5376, the Build Back Better Act. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 5376, Inflation Reduction Act of 2022. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 5376, Inflation Reduction Act of 2022. H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act of 2022. H.R. 7667, Food and Drug Amendments of 2022.

Monitor legislative and federal activity related to tax reform. Monitor legislative and administrative action related to corporate and international tax, including issues related to tax code sections 172, 245A, 951A, 59A, 163(j), and 965. Monitor legislative and administrative action related to implementation of P.L. 115-97, Tax Cuts and Jobs Act. Monitor legislative and administrative action related to net operating loss (NOL) tax issue. Monitor legislative and administrative action related to including dietary supplements as reimbursable expenses in tax-preferred savings accounts. Build Back Better proposals, including H.R. 5376, the Build Back Better Act. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and federal activity related to tax reform. Monitor legislative and administrative action related to corporate and international tax, including issues related to tax code sections 172, 245A, 951A, and 965. Monitor legislative and administrative action related to implementation of P.L. 115-97, Tax Cuts and Jobs Act. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act). Monitor legislative and administrative action related to net operating loss (NOL) tax issue. Monitor legislative and administrative action related to including dietary supplements as reimbursable expenses in tax-preferred savings accounts. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 1319, American Rescue Plan Act of 2021. Build Back Better proposals, including those in potential budget reconciliation packages.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to agricultural chemistry. Monitor legislative and administrative action related to biotechnology. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. S. 278, Emergency Relief for Farmers of Color Act of 2021. H.R. 1319, American Rescue Plan Act of 2021. Build Back Better proposals, including those in potential budget reconciliation packages.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to agricultural chemistry. Monitor legislative and administrative action related to biotechnology. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Protect Americas Children from Toxic Pesticides Act (no bill number yet). S. 278, Emergency Relief for Farmers of Color Act of 2021. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and federal activity related to tax reform. Monitor legislative and administrative action related to corporate and international tax, including issues related to tax code sections 172, 245A, 951A, and 965. Monitor legislative and administrative action related to implementation of P.L. 115-97, Tax Cuts and Jobs Act. Monitor legislative and administrative action related to net operating loss (NOL) tax issue. Monitor legislative and administrative action related to including dietary supplements as reimbursable expenses in tax-preferred savings accounts. Build Back Better proposals, including those in potential budget reconciliation packages. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to agricultural chemistry. Monitor legislative and administrative action related to biotechnology. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Protect Americas Children from Toxic Pesticides Act (no bill number yet). S. 278, Emergency Relief for Farmers of Color Act of 2021. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. Build Back Better proposals, including H.R. 5376, the Build Back Better Act.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 1319, American Rescue Plan Act of 2021. Build Back Better proposals, including those in potential budget reconciliation packages.

Monitor legislative and administrative action on appropriations and budget. Build Back Better proposals, including H.R. 5376, the Build Back Better Act. H.R. 3684, Infrastructure Investment and Jobs Act.

Monitor legislative and administrative action on appropriations and budget. Build Back Better proposals, including those in potential budget reconciliation packages. H.R. 3684, Infrastructure Investment and Jobs Act. H.R. 5376, To provide for reconciliation pursuant to title II of S. Con. Res. 14.

Monitor legislative and administrative action related to social justice issues. Executive Order on Combating Race and Sex Stereotyping. H.R. 5, Equality Act.

Monitor legislative and administrative action related to social justice issues. Executive Order on Combating Race and Sex Stereotyping. H.R. 5, Equality Act.

Monitor legislative and administrative action related to social justice issues. H.R. 5, Equality Act.

Monitor legislative and administrative action related to social justice issues. Executive Order on Combating Race and Sex Stereotyping. H.R. 5, Equality Act.

Monitor legislative and federal activity related to tax reform. Monitor legislative and administrative action related to corporate and international tax, including issues related to tax code sections 172, 245A, 951A, 59A, 163(j), and 965. Monitor legislative and administrative action related to implementation of P.L. 115-97, Tax Cuts and Jobs Act. Monitor legislative and administrative action related to net operating loss (NOL) tax issue. Monitor legislative and administrative action related to including dietary supplements as reimbursable expenses in tax-preferred savings accounts. Build Back Better proposals, including H.R. 5376, the Build Back Better Act. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to copay assistance. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. Monitor legislative and administrative action related to telehealth expansion. Monitor legislative and administrative action related to a WTO IP waiver. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. Build Back Better proposals, including H.R. 5376, the Build Back Better Act.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to agricultural chemistry. Monitor legislative and administrative action related to biotechnology. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Monitor legislative and administrative action related to the programs of the Natural Resources Conservation Service (NRCS). Build Back Better proposals, including H.R. 5376, the Build Back Better Act.

Monitor legislative and administrative action on appropriations and budget. Build Back Better proposals, including H.R. 5376, the Build Back Better Act. H.R. 3684, Infrastructure Investment and Jobs Act.

Monitor legislative and administrative action on appropriations and budget. Build Back Better proposals, including those in potential budget reconciliation packages. H.R. 3684, Infrastructure Investment and Jobs Act. H.R. 5376, To provide for reconciliation pursuant to title II of S. Con. Res. 14.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to agricultural chemistry. Monitor legislative and administrative action related to biotechnology. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Protect Americas Children from Toxic Pesticides Act (no bill number yet). S. 278, Emergency Relief for Farmers of Color Act of 2021. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to agricultural chemistry. Monitor legislative and administrative action related to biotechnology. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. S. 278, Emergency Relief for Farmers of Color Act of 2021. H.R. 1319, American Rescue Plan Act of 2021. Build Back Better proposals, including those in potential budget reconciliation packages.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to agricultural chemistry. Monitor legislative and administrative action related to biotechnology. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Protect Americas Children from Toxic Pesticides Act (no bill number yet). S. 278, Emergency Relief for Farmers of Color Act of 2021. H.R. 1319, American Rescue Plan Act of 2021.

Monitor legislative and administrative action on appropriations and budget. Build Back Better proposals, including those in potential budget reconciliation packages. H.R. 3684, Infrastructure Investment and Jobs Act. H.R. 5376, To provide for reconciliation pursuant to title II of S. Con. Res. 14.

Monitor legislative and administrative action on appropriations and budget. H.R. 133, Consolidated Appropriations Act, 2021 (P.L. 114-216), focusing primarily on tax, agriculture, and energy issues.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Address administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act). H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Address administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act). H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HASA/FSA provisions. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HASA/FSA provisions. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HASA/FSA provisions. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Address administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act). H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Address administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act). H.R. 1337, Saving Americas Pollinators Act of 2019. H.R. 1783, Keep Food Safe from Glyphosate Act of 2019.

Monitor legislative and administrative action related to the expansion of rural broadband. H.R. 2, Moving Forward Act. H.R. 7022, Rural Broadband Acceleration Act.

Monitor legislative and administrative action related to the expansion of rural broadband. H.R. 2, Moving Forward Act. H.R. 7022, Rural Broadband Acceleration Act.

Monitor legislative and administrative action related to the expansion of rural broadband. H.R. 2, Moving Forward Act. H.R. 7022, Rural Broadband Acceleration Act.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to the Rare Pediatric Disease Priority Review Voucher Program. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HSA/FSA provisions. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HAS/FSA provisions. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor legislative and administrative action related to cosmetics reform legislation. Monitor legislative and administrative action related to drug take back and pseudoephedrine regulation. Monitor legislative and administrative action related to COVID-19, including drug supply chain issues. Monitor legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including monograph reform and HASA/FSA provisions. H.R. 3, Lower Drug Costs Now Act of 2019. H.R. 863, DXM Abuse Prevention Act of 2019. H.R. 965, CREATES Act of 2019. H.R. 985, FAST Generics Act of 2019. H.R. 1344, Competitive DRUGS Act of 2019. H.R. 1503, Orange Book Transparency Act of 2019. H.R. 1520, Purple Book Continuity Act of 2019. S. 340, CREATES Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to agricultural chemistry. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act). Monitor legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act). H.R. 7940, Protect Americas Children from Toxic Pesticides Act. S. 3756, Renewable Fuel Feedstock Reimbursement Act of 2020. S. 4406, Protect Americas Children from Toxic Pesticides Act.

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration and approval issues. Monitor legislative and administrative action related to agricultural chemistry. Monitor legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Monitor legislative and administrative action related to biotech innovation and regulation. Monitor legislative and administrative action related to the Pet and Womens Safety Act, as authorized in the 2018 Farm Bill. Monitor legislative and administrative action related to implementation of P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act). H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act). S. 3756, Renewable Fuel Feedstock Reimbursement Act of 2020.

Monitor legislative and administrative action related to the expansion of rural broadband. H.R. 2, Moving Forward Act. H.R. 7022, Rural Broadband Acceleration Act.

Monitor legislative and administrative action related to the expansion of rural broadband. H.R. 2, Moving Forward Act. H.R. 7022, Rural Broadband Acceleration Act.

Monitor legislative and administrative action related to the expansion of rural broadband. H.R. 2, Moving Forward Act. H.R. 7022, Rural Broadband Acceleration Act.